Literature DB >> 20829662

Clinical use of polihexanide on acute and chronic wounds for antisepsis and decontamination.

T Eberlein1, O Assadian.   

Abstract

Polihexanide is an antimicrobial compound suitable for clinical use in critically colonized or infected acute and chronic wounds. Its beneficial characteristic is attributable particularly to its broad antimicrobial spectrum, good cell and tissue tolerability, ability to bind to the organic matrix, low risk of contact sensitization, and wound healing promoting effect. In addition, no development of microorganism resistance during polihexanide use has been detected to date, nor does this risk appear imminent. The aim of therapy using polihexanide is to reduce the pathogen burden in a critically colonized or infected acute or chronic wound. An increasing number of articles on the subject of wound antisepsis with polihexanide can be found in the medical literature. However, there is still little published information on the practical use of polihexanide-containing wound antiseptics. The purpose of this review article is to describe the handling and the different possibilities of use of polihexanide-containing preparations, including the currently approved indications, contraindications and reservations. The use of polihexanide is not the only therapeutic option in management of wounds; therefore, priority is also given to prior surgical debridement and clarification of the cause of the underlying disease, including appropriate therapy.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829662     DOI: 10.1159/000318267

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  7 in total

1.  Evaluation of angiogenesis, epithelialisation and microcirculation after application of polyhexanide, chitosan and sodium chloride in rodents.

Authors:  Ole Goertz; Henrik Lauer; Tobias Hirsch; Adrien Daigeler; Kamran Harati; Ingo Stricker; Marcus Lehnhardt; Leon von der Lohe
Journal:  Int Wound J       Date:  2015-03-10       Impact factor: 3.315

2.  Integrated MRSA-Management (IMM) with prolonged decolonization treatment after hospital discharge is effective: a single centre, non-randomised open-label trial.

Authors:  Bernhard Jahn; Trudy M Wassenaar; Annemarie Stroh
Journal:  Antimicrob Resist Infect Control       Date:  2016-06-14       Impact factor: 4.887

3.  Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study.

Authors:  Jürgen Pannek; Karel Everaert; Sandra Möhr; Will Vance; Frank Van der Aa; Jürg Kesselring
Journal:  BMC Urol       Date:  2020-07-08       Impact factor: 2.264

Review 4.  Assessing the risk of resistance to cationic biocides incorporating realism-based and biophysical approaches.

Authors:  Laura J Fox; Paul P Kelly; Gavin J Humphreys; Thomas A Waigh; Jian R Lu; Andrew J McBain
Journal:  J Ind Microbiol Biotechnol       Date:  2022-01-20       Impact factor: 4.258

5.  Bacterial growth kinetics under a novel flexible methacrylate dressing serving as a drug delivery vehicle for antiseptics.

Authors:  Christina Forstner; Johannes Leitgeb; Rupert Schuster; Verena Dosch; Axel Kramer; Keith F Cutting; David J Leaper; Ojan Assadian
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

Review 6.  Fundamental aspects of the local approach to cutaneous ulcers.

Authors:  Raquel Colenci; Luciana Patricia Fernandes Abbade
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

Review 7.  Wound Antiseptics and European Guidelines for Antiseptic Application in Wound Treatment.

Authors:  Zuzanna Łucja Babalska; Marzena Korbecka-Paczkowska; Tomasz M Karpiński
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.